U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 8-14, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 8-14, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 05/10/2022
Location: Virtual
Subject: Introductions and FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: DeeDee Cada, James Baumberger, Mark Del Monte, Tamar Magarik Haro (American Academy of Pediatrics);

Event Date: 05/11/2022
Location: Washington, DC
Subject: FDA Priorities and Industry Engagement
FDA Participant/Group: ERICA JEFFERSON;
Non FDA Participant/Group: Several members of the Pharmaceutical Research and Manufacturers of America (PhRMA) Board of Directors and staff

Event Date: 05/13/2022
Location: Virtual
Subject: Introductions and FDA Priorities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Amy Pisani, Erica DeWald (Vaccinate Your Family);

Event Date: 05/13/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Hubert Allen, Robert Ford, Thomas Evers (Abbott);

Event Date: 05/13/2022
Location: Virtual
Subject: FDA Update
FDA Participant/Group: ELENI ANAGNOSTIADIS;
Non FDA Participant/Group: Several members of the American College of Rheumatology Board of Directors and staff

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 05/09/2022
Location: Virtual
Subject: University of California San Francisco (UCSF) Idea to Impact (I2I) Session with Janet Woodcock
FDA Participant/Group: N/A
Non FDA Participant/Group: Surgery residents and pre-medical interns

Event Date: 05/11/2022
Location: Virtual
Subject: Critical Path Institute (C-Path) Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Klaus Romero, Kristen Swingle, Tim Franson, Wain Fishburn (C-Path);

Event Date: 05/11/2022
Location: Bethesda, MD
Subject: Duke Clinical Research Institute (DCRI) Think Tank; Preparing for the Next Pandemic: From Emergency Use Authorization (EUA) to Beyond - Fireside Chat
FDA Participant/Group: PETER MARKS; TIMOTHY STENZEL; PETER STEIN;
Non FDA Participant/Group: Key experts representing academia, government agencies, industry, and the patient community

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 05/12/2022
Location: Virtual
Subject: Food Safety Summit; Speaker: FDA Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Leaders and key stakeholders from government, regulatory and academia communities, retailers, food processors, distributors, food manufacturers, growers, foodservice, testing laboratories, importing/exporting, law firms, and other food safety professionals

Event Date: 05/13/2022
Location: Virtual
Subject: FDA Food Program Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several staff from the U.S. House of Representatives Committee on Energy and Commerce, Subcommittee on Oversight and Investigations

Event Date: 05/13/2022
Location: Virtual
Subject: Infant Formula Shortages
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members and staff from the U.S. Senate Democratic Caucus

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 05/11/2022
Location: Washington, DC
Subject: Winston and Strawn Health Care and Life Sciences Summit; Speaker: FDA Policy and Impact on Regulatory and Business Priorities for Pharmaceutical and Medical Device Manufacturers
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from industry and regulatory interests

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

Event Date: 05/10/2022
Location: Rockville, MD
Subject: Joint Human and Animal Food Program Committee Annual Meeting; Speaker: Welcome Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: George Ferguson (Association of American Feed Control Officials (AAFCO)); Natalie Adan (Association of Food and Drug Officials (AFDO));

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 05/09/2022
Location: Virtual
Subject: American Medical Association's Webinar Series: COVID-19 - What Physicians Need to Know; Episode 11: Fourth Dose Boosters and Pediatric Vaccine Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of American Medical Association's Webinar Series: COVID-19 - What Physicians Need to Know

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 05/09/2022
Location: Virtual
Subject: Polymerase Chain Reaction (PCR) Molecular Laboratory Developed Test
FDA Participant/Group: TIMOTHY STENZEL;
Non FDA Participant/Group: Adam Kenvarg, Dave Scheinman, Jessica Wasserman (SummerBio);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Michele Mital, Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top